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Abstract
The development and application of methods for the laboratory evolution of biomolecules has 
rapidly progressed over the last few decades. Advancements in continuous microbe culturing and 
selection design have facilitated the development of new technologies that enable the continuous 
directed evolution of proteins and nucleic acids. These technologies have the potential to support 
the extremely rapid evolution of biomolecules with tailor-made functional properties. Continuous 
evolution methods must support all of the key steps of laboratory evolution—translation of genes 
into gene products, selection or screening, replication of genes encoding the most fit gene 
products, and mutation of surviving genes—in a self-sustaining manner that requires little or no 
researcher intervention. Continuous laboratory evolution has been historically used to study 
problems including antibiotic resistance, organismal adaptation, phylogenetic reconstruction, and 
host-pathogen interactions, with more recent applications focusing on the rapid generation of 
proteins and nucleic acids with useful, tailor-made properties. The advent of increasingly general 
methods for continuous directed evolution should enable researchers to address increasingly 
complex questions and to access biomolecules with more novel or even unprecedented properties.
Introduction
Initially demonstrated as a surrogate for Darwinian evolution by Spiegelman and coworkers 
almost five decades ago [1], continuous directed evolution has long been envisioned as a 
potentially highly efficient method to discover novel biomolecules with activities of interest. 
In Spiegelman’s seminal study, Q bacteriophage genomic RNA was amplified based on its 
ability to serve as a substrate for purified Q RNA-dependent RNA-replicase. After 74 serial 
passages of this RNA genome, a variant was produced that was both 83% smaller and could 
be replicated 15 times faster than the starting Q RNA genome. Importantly, this study 
highlighted the critical nature of selection pressure design, as the evolved Q RNA genome 
could be replicated at a significantly faster rate than the parental genome, but could no 
longer direct the synthesis of viral particles since this requirement was not implicit in the 
selection.
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Thirty years later, Joyce and coworkers described the first system for the continuous 
directed evolution of catalytic function. The researchers established a self-sustaining RNA 
replication cycle for RNA molecules capable of catalyzing their own ligation to an RNA-
DNA substrate [2]. Like the Q system, the RNA ligase ribozyme continuous evolution 
system relied on exogenously supplied materials (reverse transcriptase and T7 RNA 
polymerase). Since these early studies, a number of additional continuous directed evolution 
systems have been described, the majority of which are limited to either catalytic RNAs or 
involve the evolution of alternative RNA functions [2–7]. Additionally, these methods have 
been exclusively carried out in vitro, where the comparative ease of manipulation and 
selection stringency adjustment can be exploited compared to in vivo methods. Nevertheless, 
these early landmark studies vividly demonstrated the potential of continuous directed 
evolution and provided a foundation for subsequent advances.
All forms of Darwinian evolution must support four fundamental processes: translation 
(when the evolving molecule is not identical to the information carrier), selection, 
replication, and mutation (Figure 1). Traditional directed evolution methods handle each of 
these processes discretely, frequently requiring steps in which the researcher must perform 
experimental manipulations. In contrast, continuous directed evolution systems must 
seamlessly integrate all of these processes into an uninterrupted cycle. For the purposes of 
this review, we define continuous directed evolution as a general method capable of 
evolving a specific phenotype, at the level of an organism or a set of genes, over many 
cycles of mutation, selection, and replication with minimal researcher intervention. A 
continuous evolution method therefore must support all four stages of Darwinian evolution 
and allow the surviving genes from one generation to spontaneously enter the translation, 
selection, replication, and mutation processes of the subsequent generation.
Many key studies on continuous evolution have relied on manual serial dilution of the 
evolving population as a mechanism for propagating genes and controlling selection 
stringency. We do not consider this technical manipulation to violate our definition, as such 
systems have been shown to be amenable to automation, yielding similar results [8]. While 
in vivo continuous evolution methods have exploited the natural occurrence of the three 
steps of Darwinian evolution in living organisms, these methods have also historically been 
constrained by modest scope, often focusing on easily selected phenotypes such as antibiotic 
resistance rather than traits associated with diverse applications and unmet needs. Recently, 
more general in vivo continuous directed evolution methods have been developed using 
various organisms, ranging from viruses to bacteria to higher eukaryotes. In this review, we 
highlight a sampling of recent developments in the field of in vivo continuous directed 
evolution over the past two decades and their impact, both realized and prospective, on the 
directed evolution community.
Viral Continuous Evolution
With their high mutation rates [9] and relative ease of manipulation and study, 
bacteriophages were used early on as model organisms for rapid directed evolution of 
readily selectable traits [10]. Moreover, the development of methods for continually 
culturing bacterial strains has greatly reduced the barrier for studying bacteriophage 
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evolution under continuous selection pressure [10,11]. Of historical note is the early and 
widespread use of both chemostats, cultures maintained through the continuous inflow of 
fresh growth medium, and auxostats, cultures regulated by a feedback mechanism that 
controls the inflow of growth medium based on a monitored culture parameter (Figure 2). 
Both methods have proven useful in continuous culturing of bacteriophage-infectable 
microbes. Methods for bacterial continuous evolution will be covered in the next section.
Among the earliest examples of viral continuous evolution is the 1997 work of Molineux 
and coworkers using X174, a bacteriophage capable of propagating using E. coli or S. 
typhimurium [12,13]. These studies highlighted the ability of this phage to rapidly adjust to 
novel environments such as higher temperatures, as well as an abnormally high degree of 
mutational convergence depending on selection conditions. Additionally, substantial 
improvements in phage fitness were observed over relatively short time frames, with an 
average of 1–2 mutations per 24 hours (corresponding to 0.2–0.5 % of the viral genome, and 
0.003–0.005 mutations per generation per kilobase) in the absence of any added mutagens. 
In an expansion of this work by Bull and coworkers, X174 phage was propagated on 
bacterial hosts under native conditions for six months, corresponding to ~13,000 phage 
generations [14]. Mutations continued to accumulate at a constant rate for the majority of the 
experiment, suggesting a potential arms race within the propagating phage pool. The 
researchers speculated that this arms race was driven by the high concentration of phage 
with respect to host cells, resulting in high levels of co-infection and competition between 
phage. While the mutation rates observed under these conditions were high with respect to 
the size of the viral genome and sufficient for rapid phage adaptation, higher rates are 
typically required to access gene-specific evolution goals (1–2 mutations per round per 
gene) [15].
Similar phage propagation experiments were carried out by Molineux and coworkers using 
bacteriophage T7 to study organismal phylogenetic histories [16]. To enhance the mutation 
rate, T7 phage was serially passaged in the presence of the chemical mutagen MNNG (N-
methyl-N’-nitro-N’-nitrosoguanidine), resulting in variants with differential restriction 
enzyme cleavage patterns than the wild-type phage. The correct phylogeny of the diverging 
phage populations could be determined using these cleavage patterns, supporting their 
method for phylogenetic reconstruction and suggesting maximization of parsimony as a 
promising method for determining ancestral characteristics. While this approach addressed 
the need for high mutagenesis rates during evolution, the selection was highly qualitative, 
requiring the accumulation of non-deleterious mutations that enabled restriction enzyme 
profiling. A similar strategy was later used by the same group to study the effects of 
successive severe population bottlenecking and expansion on viral fitness, demonstrating the 
remarkable plasticity of the T7 genome towards mutations and the interdependence of the 
accumulated mutations in specific phage linages [17]. These studies also highlight the utility 
of user-defined mutagenesis rates in continuous directed evolution, although chemical 
mutagens generally offer narrow mutational spectra and are potent carcinogens.
Recently, T7 phage was used by Barrick and coworkers to study organismal adaptation to an 
expanded genetic code [18]. Two versions of this phage, wild-type T7 and the 2 T7 
hypermutator, were serially propagated using an E. coli strain capable of efficiently 
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incorporating 3-iodotyrosine at amber stop codons. The use of a genetically encodable 
hypermutator resulted in broad mutational load to the T7 phage without the hazards typically 
associated with alternative chemical mutagens. Notably, two amber codon substitutions 
reached high frequencies in the evolving populations: Tyr88Amber in T7 RNA polymerase 
(T7 RNAP) and Tyr39Amber in T7 type II holin. Whereas the mutation in the RNAP was 
assumed to be tolerated due to a lack of interaction of this surface-exposed side chain with 
the remainder of the protein, the mutation in the type II holin was shown to be critical for 
function in the amber suppressor strain. The findings of this study suggest that an expanded 
genetic code may increase the evolvability of an organism.
Lambda bacteriophage has been used extensively to study host-virus interactions. Lambda 
phage natively recognizes LamB as the main point of entry into E. coli. Using a strictly lytic 
lambda phage, Lenski and coworkers studied the ability of this phage to continuously evolve 
the ability to use alternative outer membrane receptors as the point of entry [19]. Upon co-
culturing this phage with host cells in glucose-limited conditions, the bacteria rapidly 
evolved resistance through downregulation of lamB expression. The mutating pool of 
lambda phage then evolved compensatory mutations in the LamB recognition protein J, 
resulting in improved fitness on LamB, as well as facilitating the use a new receptor, OmpF. 
In response, the E. coli host reduced fitness of the mutant lambda phage through mutations 
to manYZ, two proteins that form an inner membrane channel required for lambda phage 
entry. This coevolution highlights the utility of continuous evolution methods in revealing 
the dynamic interplay between host and virus evolution.
While these systems have enhanced our understanding of fundamental aspects of evolution, 
they generally are limited by an uncontrolled (usually low) mutagenesis rate intrinsic to the 
bacteriophage and host, and/or the requirement for broad organismal adaptation to an 
environmental challenge, rather than enabling the evolution of a specific biomolecular 
activity of interest. Our group has developed a bacteriophage-based continuous evolution 
system that attempts to address these two limitations. Phage-assisted continuous evolution 
(PACE) is a general system for the directed evolution of biomolecules that relies on 
previously discussed methods for the continued culturing of E. coli, can be used to evolve, 
in principle, any activity that can be coupled to gene transcription in E. coli, and allows real-
time modulation of selection stringency and mutagenesis levels [20].
Briefly, PACE takes advantage of the critical role of the minor coat protein pIII from the 
filamentous bacteriophage M13 during both infection and progeny release [21]. Phage 
lacking functional pIII have virtually no ability to propagate and are rapidly lost under 
continuous culturing conditions. However, host cell-provided pIII restores the virulence of 
the phage and allows robust phage propagation in continuous culture. Accordingly, phage-
borne genes encoding the ability to trigger pIII in host cells gain a fitness advantage and 
propagate at the expense of unfit phage. To increase the mutation rate during PACE, an 
inducible plasmid driving the expression of error-prone E. coli polymerase subunits results 
in ~100-fold increased mutagenesis with a more-uniform distribution of mutations as 
compared to traditional chemical mutagens [20]. Due to the continuous flow nature of this 
system, mutations accumulate only within the phage genome and the gene to be evolved, 
reducing the likelihood of “cheaters” overtaking the population during selection.
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PACE was initially used to evolve novel activity in T7 RNAP [20]. Whereas T7 RNAP 
efficiently initiates transcription using the native T7 promoter, it lacks detectable activity on 
the related T3 promoter. Using a combined T7/T3 promoter as an evolutionary stepping-
stone, T7 RNAP variants capable of efficiently initiating transcription from the T3 promoter 
were evolved within a few days. This method has since been expanded to address the effects 
of varying levels of mutagenesis and selection stringency on enzyme evolution [22], the path 
dependence of convergent protein evolution [23], the effects of neutral drift, negative 
selection, and stringency modulation on enzyme evolution [24], and the rapid evolution of 
protease enzymes from pathogenic viruses that predict how viral proteases evade clinically 
relevant antiviral drugs [25]. This system has been further modified to enhance its ability to 
serve as a basis for alternative selection schemes, and ongoing studies use PACE to mediate 
the continuous directed evolution of DNA-binding domains, protein-protein interactions, 
genome modification enzymes, proteases, and other enzymes [25].
Bacterial Continuous Evolution
Mechanisms that enable the efficient and unmonitored continuous propagation of bacteria 
and other microorganisms have served as a key component of many continuous evolution 
methods. While their utility has been extensively demonstrated for bacteriophage evolution 
efforts as highlighted in the previous section, these methods have also facilitated the study of 
continuous directed evolution of bacterial populations, especially in cases where the gene to 
be evolved is large or cannot be directly coupled to viral fitness. A recent demonstration 
assesses the evolution of population-wide antibiotic resistance. Using a continuous culture 
of E. coli, Collins and coworkers added increasing concentrations of the antibiotic 
norfloxacin to study population dynamics during increasing antibiotic selection pressure 
[26]. Surprisingly, the researchers found that single members of the population were, on 
average, less resistant to the antibiotic than the population as a whole. Additionally, resistant 
members were found to produce high levels of indole, a signaling molecule used by the 
surrounding, less resistant members to induce protective mechanisms against the antibiotic.
In a related study, Kishony and coworkers followed parallel populations of E. coli under 
differing antibiotic selection pressures using a bacterial culture device termed the 
morbidostat [27]. Unlike the previous study in which the concentration of antibiotic is 
adjusted in 24-hour intervals, the morbidostat continuously adjusts the concentration of the 
antibiotic to maintain a nearly constant selection pressure (as judged by changes in cell 
density, thereby making it a variation on the prototypical auxostat). The parallel populations 
were challenged with different antibiotics, and followed using whole-genome sequencing to 
assess the nature of the mutations endowing the populations with antibiotic resistance. For 
chloramphenicol and doxycycline, resistance proceeded through multiple pathways, 
ultimately resulting in similar levels of antibiotic resistance using different sets of mutations. 
Conversely, resistance to trimethoprim proceeded through a highly sequential series of 
mutations in DHFR and its associated promoter in all the parallel populations. Importantly, 
many resistance mutations that had been previously identified using plate-based methods 
were not found in this study, highlighting variable fitness costs for some mutations 
depending on selection conditions, and the stochasticity of evolution under selection 
conditions for which many potential pathways to increased fitness exist.
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For some applications the basal rate of bacterial mutagenesis may not be high enough to 
provide access to necessary genetic changes on a practical timescale. Methods for the 
unbiased, yet targeted, mutagenesis of bacteria would dramatically facilitate these 
applications. An ideal method would require that the evolving gene(s) be replicated by an 
orthogonal, error-prone polymerase enzyme. One such system uses the E. coli DNA 
polymerase I (Pol I). Bacteria lacking Pol I are viable, suggesting that manipulation of this 
polymerase might be tolerated. Loeb and coworkers used previously reported mutations that 
increase the error rate of Pol I to continuously evolve TEM beta-lactamases capable of 
hydrolyzing a third-generation lactam antibiotic, aztreonam [28]. Three serial dilutions of a 
growing bacterial culture in increasing concentrations of aztreonam strongly enriched 
clinically relevant TEM mutations. The utility of this technique extends beyond the 
continuous directed evolution of antibiotic resistance, as it also enables the potent and 
targeted in vivo mutagenesis of a gene of interest. It should be noted, however, that an 
inverse relationship exists between the length of the gene of interest and the mutagenesis 
rate using this system and others that depend on Pol I mutants [28,29].
Bacterial continuous evolution has also been used to evolve phenotypes other than antibiotic 
resistance. The E. coli DNA polymerase III epsilon subunit DnaQ is responsible for the 
proofreading activity of most DNA replication. Dominant-negative variants of DnaQ 
provided in trans are known to have dramatic consequences on replication fidelity [30]. 
Integrating these principles, Ma and coworkers constructed a library of dnaQ mutants using 
error-prone PCR to be expressed constitutively in continuously growing bacterial cultures 
[31]. Selection pressures in the form of increasing concentrations of n-butanol or acetic acid 
were applied to the growing cultures. Plasmids carrying mutagenic dnaQ variants should be 
enriched at high concentrations of n-butanol or acetic acid because they endow their hosts 
with the ability to more quickly adapt to the strong selection pressure. Within 24 to 36 days 
of continuous evolution, the E. coli populations became adapted to the high solvent 
concentrations. As the researchers predicted, all the dnaQ variants that evolved in surviving 
cells were more mutagenic than the wildtype dnaQ, increased the mutation rate by up to 
2,800-fold, and contained mutations known to dramatically enhance mutagenesis [30,31].
All of these examples of bacterial continuous evolution rely on the manual passaging of the 
bacteria being studied, or use an automated variant of a chemostat or auxostat. In either case, 
biofilm formation can dramatically affect the success of the experiment, as bacteria are 
known to attach to the culture vessel wall upon extended propagation. To ameliorate this 
issue, an apparatus dubbed the “GM3 cultivation device” was recently developed to allow 
the maintenance of steady-state microbial growth over extremely long timeframes (Figure 
3). This apparatus uses two growth chambers that are cyclically used to culture the microbe 
of interest, with alternating rounds of chemical sterilization that ensure that members of the 
population do not escape selections for faster growth through biofilm formation.
In one application of the GM3 device, Mutzel and coworkers evolved E. coli containing the 
large-scale substitution of chromosomal thymine with 5-chlorouracil [32]. The researchers 
used a thymine auxotroph grown in continuous culture on two types of media: a permissive 
media with all essential nutrients including thymine, and a selective media of similar 
composition with the exception of thymine, which was substituted with 5-chlorouracil. To 
Badran and Liu Page 6
Curr Opin Chem Biol. Author manuscript; available in PMC 2016 February 01.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
slowly modulate selection stringency they mixed varying ratios of the two media, starting 
from 100% thymine-containing media and slowly transitioning to 100% 5-chlorouracil-
containing media over six months. By the end of the experiment, strains with a significant 
number of mutations or chromosomal rearrangements that could grow using 5-chlorouracil 
were isolated. These strains were capable of incorporating 5-chlorouracil at levels up to 90% 
of the chromosomal DNA, with the remaining 10% attributed to thymine. After further 
optimization, the fraction of chromosomal thymine was reduced to less than 2% through 
removal of a cryptic pathway to thymine deoxynucleotide production.
In another application of the same device, Hilvert and coworkers continuously evolved an 
artificial chorismate mutase enzyme that had been previously designed using a nine-amino-
acid code [33]. Chorismate mutase natively converts chorismate to prephenate in the 
shikimate pathway, a critical step in the biosynthesis of the aromatic amino acids 
phenylalanine and tyrosine. A strain of E. coli lacking wild-type chorismate mutase and 
expressing the artificial variant was continuously propagated for more than 200 days, 
initially in low phenylalanine-containing media and slowly transitioning to media lacking 
both phenylalanine and tyrosine. Bacteria carrying improved chorismate mutase mutants 
grew at a faster rate in the restrictive media, resulting in their enrichment over the course of 
the experiment. By the end of the experiment, chorismate mutase variants that expanded the 
nine amino acid code to ten or eleven amino acids could be isolated, and mutants generally 
had improved activity as compared to the parent. This study suggests that expanded genetic 
codes can result in improved evolvability, a similar conclusion to those reached by Barrick 
and coworkers using 3-iodotyrosine incorporation in T7 bacteriophage [18].
Eukaryotic Continuous Evolution
Viral and bacterial hosts are not suitable for the directed evolution of biomolecules in certain 
scenarios. In cases of industrial drug precursor production [34] or whole-cell biocatalysis 
[35], higher organisms with more extensive or relevant biosynthetic pathways may be 
necessary. Towards this end, continuous directed evolution techniques using eukaryotic 
organisms have also been developed.
In one of the earliest examples of eukaryotic continuous evolution, the Evolugator, a 
proprietary continuous culturing device that reduces biofilm formation and wall growth 
(Figure 4), was used to evolve thermotolerant filamentous fungi. During long-term 
continuous culturing of filamentous fungi, wall growth can be problematic as fungal cells 
rapidly aggregate, leading to non-uniform culture dilution. To circumvent this issue, de 
Crécy-Lagard and coworkers devised an alternative method for continuous fungi culturing 
that dramatically ameliorates fungal wall growth [36,37]. Using this platform over the 
course of four months, the researchers evolved two thermotolerant variants of the 
entomopathogenic fungus Metarhizium anisopliae to facilitate the widespread adoption of 
this fungus for pest control [37]. While successful, this method for continuous directed 
evolution requires specialized equipment that cannot be readily generalized to alternative 
selection methodologies.
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Cornish and coworkers recently noted that many in vivo selection methods do not take 
advantage of genetic recombination as a source of diversification, and reasoned that the 
selective induction of double-stranded breaks (DSBs) with high efficiency could 
dramatically increase the degree of recombination in Saccharomyces cerevisiae [38]. They 
developed a yeast continuous evolution system made of three parts: a plasmid that tightly 
controls the expression of the site-specific endonuclease I-SceI, a cassette plasmid that 
contains regions of homology to the target sequence flanked by I-SceI cleavage sites, and a 
target plasmid carrying the gene to be mutagenized. Upon induction of the endonuclease, the 
mutagenic cassette is liberated from its respective plasmid and goes on to mutate the region 
of interest through homology-directed recombination [38]. Using this system, the authors 
were able to evolve hisA variants capable of complementing trp1 auxotrophy in yeast in less 
than one month. This system is accessible and potentially powerful but requires knowledge 
of the relevant regions of a gene to mutate since genetic diversity is dependent on 
homology-directed recombination.
One of the most useful features of a continuous directed evolution system is the ability to 
modulate the mutagenesis of the evolving genes in a manner that does not perturb either the 
selection or the organism. This feature was one of the major design considerations for the 
development of the PACE platform [20], in which mutations accumulate only in replicating 
phage; the error-prone bacterial Pol I variants [28], in which mutations accumulate only in 
ColE1-type origin vectors; and the I-SceI-based yeast recombination system [38], in which 
mutations are restricted to regions highly homologous to the mutagenic cassette. All of these 
systems largely abrogate or avoid host strain mutagenesis. A similar approach was recently 
developed by Chang Liu and coworkers using a system that is completely contained in yeast. 
The authors used an autonomous DNA replication system from Kluveromyces lactis to 
enable the replication of a gene of interest in the S. cerevisiae cytosol [39]. Due to the strict 
requirements for the orthogonal K. lactis DNA polymerase initiation, no crosstalk was 
observed between the K. lactis components and the native host machinery. To make this 
system more amenable to directed evolution, the authors used a homology-guided approach 
to create error-prone DNA polymerase variants that would only replicate the orthogonal 
plasmid. The optimized system was able to induce ~300× higher rates of mutagenesis in the 
orthogonal plasmid as compared to the background S. cerevisiae mutagenesis rate, with no 
reduction in the genomic replication fidelity. This system represents an important 
methodological advance in continuous directed evolution in eukaryotes.
Conclusion
Methods for the directed evolution of biomolecules have proven to be important 
technologies for generating new functional proteins and nucleic acids as research tools and 
therapeutics, as well as for facilitating the investigation of fundamental biological questions. 
Some of the limitations of traditional stepwise laboratory evolution approaches can be 
overcome by continuous directed evolution platforms. Continuous directed evolution 
intrinsically enables a broader exploration of sequence space in a practical timescale 
compared to traditional discrete laboratory evolution methods. Indeed, in vivo continuous 
evolution methods can enable > 1011 protein variants to be generated and subjected to 
selection over > 100 generations of evolution in less than a week [20]. The efficiency of 
Badran and Liu Page 8
Curr Opin Chem Biol. Author manuscript; available in PMC 2016 February 01.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
continuous evolution methods can enable long evolutionary trajectories [14,23,32,33] or 
access to highly evolved biomolecules with new properties that would otherwise require 
impractical time scales [1,2,18,24,27,31,38]. In addition, some continuous evolution 
platforms, including several described above, can avoid genetic bottlenecks from modest 
population sizes, modest screening throughput, or modest mutation rates that commonly 
constrain some traditional laboratory evolution methods. The minimal reliance on researcher 
intervention during continuous evolution can also make performing multiple parallel 
evolution experiments more accessible than using traditional directed evolution platforms 
[12–14,18–20,22–24,27,31,39].
Continuous directed evolution methods are not without their own drawbacks and should be 
considered a complement, rather than a replacement, to other laboratory evolution 
approaches. Establishing a continuous cycle of translation, mutation, selection, and 
replication that is general for a range of biomolecules is challenging, and therefore most 
continuous evolution methods perform these key steps inside cells. As a result, while 
traditional in vitro directed evolution techniques enable exquisite control of selection 
stringency and mutation rate through simple adjustments of additive concentrations, 
analogous perturbations are more difficult to implement in vivo and generally must be 
empirically determined. Because in vivo continuous evolution platforms typically require 
continuous culture of microorganisms, contamination either by “cheaters” (uninteresting 
gene variants that bypass selections) or by inoculation with undesired organisms poses 
additional hurdles for implementing these methods.
Finally, the development of selection methods compatible with continuous evolution is 
typically more difficult than the development of analogous selections or screens for 
traditional stepwise laboratory evolution methods. Evolved biomolecules with desired 
properties in a continuous evolution system must be linked to gene and organism replication, 
rather than to the generation of fluorescent or colorimetric signals that have proven to be 
robust staples of in vitro and cell-based screening. While establishing this linkage between 
desired biomolecule function and cell survival is relatively straightforward for genes that are 
natively associated with organismal fitness (such as antibiotic resistance, temperature or 
solvent tolerance, or improved growth rate), the design of selections for continuous 
evolution is more challenging for genes and gene products that do not intrinsically affect 
cellular survival. Fortunately, many creative strategies have been described for coupling a 
wide variety of molecular activities to cell survival, including protein-fragment 
complementation of enzymatic activities and organelle-specific localization signals, n-
hybrid systems for binding activity and bond-formation catalysis [40,41], derepression-
based methods for bond-cleaving activities [42], gene regulation-based selections for 
activities associated with transcription or translation [43], and cis-acting elements for 
metabolite sensing [44]. We anticipate that the expansion of such selection methods to 
address an increasingly broad scope of molecular problems of interest will play a key role in 
fully realizing the potential and defining the future impact of continuous directed evolution.
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Highlights
1. General and recent advances in the field of in vivo continuous evolution
2. Advances in the continuous culture of microbes have enabled continuous 
evolution
3. Viruses, prokaryotes, and eukaryotes have mediated in vivo continuous 
evolution
4. Continuous evolution studies have contributed insights into evolutionary 
biology
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Figure 1. Schematic representation of directed evolution
All complete directed evolution methods must provide four major components: translation, 
selection or screening, replication, and mutation. Historical examples of each of these 
components are listed. Techniques that are particularly amenable to in vivo continuous 
evolution are shown in green.
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Figure 2. Auxostats and chemostats
Fresh culture medium is pumped into a pre-sterilized container containing the 
microorganism of interest. Medium with cells is pumped out of the culture container. The 
rates of medium input and output are held constant in a chemostat system, and the growth 
rate is regulated by the composition of the medium. In an auxostat system, the medium flow 
rates are dynamically regulated by a controller in response to measurements made in the 
growing culture, which correspond directly (turbidity meter) or indirectly (other sensors) to 
the culture density. In schemes for viral continuous evolution, the auxostat or chemostat 
culture is pumped into a new vessel where the virus of interest is supplied (cellstat). Both 
cultures can be supplemented with additives supplied through a dedicated inlet. Selection 
stringency can be regulated by varying flow rates, changing temperature, or adding 
compounds to the auxostat, chemostat or cellstat. The depleted medium, cells and virus are 
pumped to a waste container.
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Figure 3. The GM3 cultivation device
A growing culture in the first vessel is supplemented with a defined ratio of relaxing and 
stressing medium. This ratio is regulated by a controller connected to a turbidity meter 
measuring cell density. After a defined growth time, the whole culture is transferred to the 
second vessel to limit selection escape through biofilm formation. Following this transfer, 
the first vessel is sterilized with 5 M NaOH and washed extensively to limit contamination. 
After another defined growth period in the second vessel, the growing culture is transferred 
back to the first vessel, and the cycle is repeated. The selection stringency is modulated 
through the ratio of the relaxing and stressing media, ultimately reaching up to 100% 
stressing medium. The depleted medium and cells are pumped to a waste container.
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Figure 4. Growth chamber of the Evolugator
a) The growing culture is shown on the right, and is completely contained within a tube 
clamped at regular intervals to limit unintentional mixing. The density of the culture is 
measured with a turbidity meter connected to a controller that dynamically regulates the in-
flux of new medium. Air bubbles are included at regular intervals to increase the 
oxygenation level of the medium. b) Upon reaching high density, the right clamp closes, the 
tubing moves along the track, and the next clamp opens allowing for contact between the 
growing culture and the fresh medium. c) The fresh medium mixes with the growing culture 
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through diffusion, and the culture resumes growing. d) After sufficient time, the culture 
again reaches high density. The middle clamp then closes, the tubing shifts on the track once 
again, the next clamp opens and the new medium is allowed in. This cycle is then continued 
for the duration of the experiment.
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